Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-07-27

FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)

View source ↗

Summary

The FDA approved a supplemental application for the lamotrigine generic product from Alembic Pharmaceuticals Limited, reflecting a regulatory update for this pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lamotrigine (lamotrigine)

Snippet

SUPPL AP for LAMOTRIGINE (LAMOTRIGINE)